Literature DB >> 11891182

Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice.

Christine A Kostek1, Janice A Dominov, Jeffrey Boone Miller.   

Abstract

We found that up-regulation of major histocompatibility complex (MHC) class I expression accompanies, but is not required for, appearance of spontaneous myopathy in SJL/J mice. In some neuromuscular diseases, MHC class I expression is markedly up-regulated in muscles, though the consequences of this up-regulation for pathology are not clear. To study MHC class I in myopathy, we compared muscles of SJL/J mice to muscles of SJL/J mice that were also MHC class I-deficient due to targeted mutation in the beta-2-microglobulin gene (SJL/J B2m (-/-) mice). SJL/J mice show spontaneous myopathy and have a mutation in the dysferlin gene, a gene which is also mutated in human limb-girdle muscular dystrophy type 2B (LGMD2B). Muscles of eight-month-old SJL/J mice had higher levels of MHC class I expression than muscles of either C57BL/6J (wild-type) or SJL/J B2m (-/-) mice. In contrast, the percentage of abnormal muscle fibers was similar in SJL/J and SJL/J B2m (-/-) muscles. Invading Mac-1(+) cells were most abundant in SJL/J B2m (-/-) muscles, moderately abundant in SJL/J muscles, and rare in C57BL/6J muscles. Thus, MHC class I was markedly up-regulated in SJL/J muscles, but this high level of MHC class I was not necessary for the appearance of myopathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891182      PMCID: PMC1867159          DOI: 10.1016/S0002-9440(10)64906-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.

Authors:  B H Koller; P Marrack; J W Kappler; O Smithies
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

Review 2.  MHC class I-deficient mice.

Authors:  D H Raulet
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

3.  Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies.

Authors:  A M Emslie-Smith; K Arahata; A G Engel
Journal:  Hum Pathol       Date:  1989-03       Impact factor: 3.466

4.  Effect of MHC class I and CD8 cell deficiency on experimental autoimmune myasthenia gravis pathogenesis.

Authors:  M Shenoy; R Kaul; E Goluszko; C David; P Christadoss
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

5.  Experimental autoimmune inflammatory myopathy.

Authors:  M N Hart; D S Linthicum; M M Waldschmidt; S K Tassell; R L Schelper; R A Robinson
Journal:  J Neuropathol Exp Neurol       Date:  1987-09       Impact factor: 3.685

Review 6.  Experimental models of inflammatory myopathies.

Authors:  N L Rosenberg
Journal:  Baillieres Clin Neurol       Date:  1993-11

7.  Expression of immunoreactive major histocompatibility complex products in human skeletal muscles.

Authors:  G Karpati; Y Pouliot; S Carpenter
Journal:  Ann Neurol       Date:  1988-01       Impact factor: 10.422

8.  The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis.

Authors:  T A Robertson; M A Maley; M D Grounds; J M Papadimitriou
Journal:  Exp Cell Res       Date:  1993-08       Impact factor: 3.905

9.  Expression of class I and class II MHC antigens in neuromuscular diseases.

Authors:  R M McDouall; M J Dunn; V Dubowitz
Journal:  J Neurol Sci       Date:  1989-02       Impact factor: 3.181

10.  Inhibition of fasL sustains phagocytic cells and delays myogenesis in regenerating muscle fibers.

Authors:  M Sandri; C Sandri; B Brun; E Giurisato; M Cantini; K Rossini; C Destro; P Arslan; U Carraro
Journal:  J Leukoc Biol       Date:  2001-03       Impact factor: 4.962

View more
  6 in total

1.  Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice.

Authors:  Monica H Kristiansson; Vadiraja B Bhat; I Ramesh Babu; John S Wishnok; Steven R Tannenbaum
Journal:  J Proteome Res       Date:  2007-03-28       Impact factor: 4.466

Review 2.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

3.  Comparative Gene Expression Analysis in the Skeletal Muscles of Dysferlin-deficient SJL/J and A/J Mice.

Authors:  Kinji Kobayashi; Takeshi Izawa; Mitsuru Kuwamura; Jyoji Yamate
Journal:  J Toxicol Pathol       Date:  2011-03-31       Impact factor: 1.628

4.  Differential immunohistological features of inflammatory myopathies and dysferlinopathy.

Authors:  Jae-Hwan Choi; Yeong-Eun Park; Sung-Il Kim; Jeong-Il Kim; Chang-Hoon Lee; Kyu-Hyun Park; Dae-Seong Kim
Journal:  J Korean Med Sci       Date:  2009-11-07       Impact factor: 2.153

5.  Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism.

Authors:  G Cenacchi; M Fanin; L B De Giorgi; C Angelini
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

6.  Dysferlin and animal models for dysferlinopathy.

Authors:  Kinji Kobayashi; Takeshi Izawa; Mitsuru Kuwamura; Jyoji Yamate
Journal:  J Toxicol Pathol       Date:  2012-06       Impact factor: 1.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.